期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
生物大分子药物传送系统及功能高效化的研究进展 被引量:2
1
作者 任国宾 董伟兵 +2 位作者 张志荣 王静康 杨志民 《华西药学杂志》 CAS CSCD 北大核心 2008年第3期363-364,共2页
综述了国内外现阶段生物大分子药物传送系统及功能高效化的进展。
关键词 生物大分子药物 药物传送系统 药物高效化
下载PDF
肝癌患者经植入性药物传送系统泵化疗并发症的护理240例
2
作者 周烨 李新省 张丽敏 《中国实用护理杂志(下旬版)》 2004年第2期15-16,共2页
关键词 肝癌 植入性药物传送系统 化疗 并发症 护理 DDS 临床资料
下载PDF
基于隐形眼镜的药物输送系统及其在眼前节疾病治疗中的应用 被引量:1
3
作者 王烽 邵毅 《国际眼科纵览》 2022年第3期236-241,共6页
滴眼液用于治疗眼前节疾病有许多局限性,如生物利用度低、剂量要求高和患者依从性差。隐形眼镜直接定位于眼表,因此基于隐形眼镜装载常规药物被用于探索治疗眼前节疾病的可行性和潜力,通过诸如简单浸泡、包含载药胶体纳米颗粒或分子印... 滴眼液用于治疗眼前节疾病有许多局限性,如生物利用度低、剂量要求高和患者依从性差。隐形眼镜直接定位于眼表,因此基于隐形眼镜装载常规药物被用于探索治疗眼前节疾病的可行性和潜力,通过诸如简单浸泡、包含载药胶体纳米颗粒或分子印迹等技术将药物掺入到隐形眼镜中。无论使用何种技术,隐形眼镜的关键特性保持不变,如透明度和透氧性。基于隐形眼镜的药物输送系统能有效预防和控制眼表感染、促进角膜损伤愈合、治疗过敏性结膜炎、改善干眼症状,降低眼压,为眼前节疾病的治疗提供新的途径。 展开更多
关键词 隐形眼镜 眼前节疾病 药物传送系统
原文传递
Modeling of highly efficient drug delivery system induced by self-assembly of nanocarriers: A density functional study
4
作者 JIANG Jian CAO DaPeng 《Science China Chemistry》 SCIE EI CAS 2013年第2期249-255,共7页
Owing to the importance of drug delivery in cancer or other diseases' therapy, the targeted drug delivery (TDD) system has been attracting enormous interest. Herein, we model the TDD system and design a novel rod-... Owing to the importance of drug delivery in cancer or other diseases' therapy, the targeted drug delivery (TDD) system has been attracting enormous interest. Herein, we model the TDD system and design a novel rod-like nanocarrier by using the coarse grained model-based density functional theory, which combines a modified fundamental measure theory for the excluded-volume effects, Wertheim's first-order thermodynamics perturbation theory for the chain connectivity and the mean field approximation for van der Waals attraction. For comparison, the monomer nanocarrier TDD system and the no nanocarrier one are also investigated. The results indicate that the drug delivery capacity of rod-like nanocarriers is about 62 times that of the no nanocarrier one, and about 6 times that of the monomer nanocarriers. The reason is that the rod-like nanocarriers would self-assemble into the smectic phase perpendicular to the membrane surface. It is the self-assembly of the rod-like nanocarriers that yields the driving force for the targeted delivery of drugs inside the cell membrane. By contrast, the conventional monomer nanocarrier drug delivery system lacks the driving force to deliver the drugs into the cell membrane. In short, the novel rod-like nanocarrier TDD system may improve the drug delivery efficiency. Although the model in this work is simple, it is expected that the system may provide a new perspective for cancer targeted therapy. 展开更多
关键词 INTERFACE POLYMERS MICROSTRUCTURE statistical thermodynamics SELF-ASSEMBLY targeted drug delivery
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部